drugset / Trial / NCT00876538

Effect of TRO19622 in the Treatment of Patients With Chemotherapy Induced Peripheral Neuropathy

NCT00876538

Phase 2 Completed 17 enrolled Hoffmann-La Roche
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to test the effect of TRO19622 on peripheral neuropathy scores after 6 weeks treatment and is based on the separate assessment of pain and dysesthesia scores.

Timeline

Start
2009-03
Primary completion
2010-09
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Olesoxime Small molecule 330 mg